meRfi®-GM
Tumor-associated antigens (TAA)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
These are normal proteins that are overexpressed in tumor cells but can also be found at lower levels in some normal tissues. Because they are derived from normal (unmutated) genes, the immune system may be tolerant to them, and targeting them can sometimes lead to autoimmune side effects
NM23 proteins are aberrantly expressed in several different tumors. NM23-H2 is a novel HLA-A32-restricted Tumor-associated antigens (TAA) of Chronic myeloid leukemia / Chronic myelogenous leukemia (CML) cells.
References:
see also:
Cancer cells / Tumor cells
Neoantigens
[…
References (Sources)
- Cancer and Innate lmmune System Interactions: Translational Potentials for Cancer Immunotherapy
- CTL-Based Cancer Preventive/Therapeutic Vaccines for Carcinomas: Role of Tumour-Associated Carbohydrate Antigens
- Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies
- Identification of NM23-H2 as a tumour-associated antigen in chronic myeloid leukaemia
- Neoantigen: A New Breakthrough in Tumor Immunotherapy
- Tumor-Associated antigens: Tn antigen, sTn antigen, and T antigen
- Tumour-Ass carbohydrate antigens in breast cancer